http://jcps.bjmu.edu.cn

Journal of Chinese Pharmaceutical Sciences ›› 2023, Vol. 32 ›› Issue (7): 598-599.

• News • Previous Articles     Next Articles

The team of Prof. Zhenjun Yang have made continuous progress in the delivery of antisense nucleic acid structural modifications in vivo and the treatment of liver cancer

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center   

  1. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
  • Received:2023-07-13 Revised:2023-07-13 Accepted:2023-07-13 Online:2023-07-31 Published:2023-08-07

Abstract:

The team of Prof. Zhenjun Yang have made continuous progress in the delivery of antisense nucleic acid structural modifications in vivo and the treatment of liver cancer.

Supporting: